Cadila Pharmaceuticals has been recognized as one of the Top 50 Innovative Companies in India at the CII Industrial Innovation Awards 2023. This prestigious accolade highlights our commitment to pioneering advancements in the pharmaceutical industry.
Raj Prakash Vyas, President of Corporate Affairs, received the award on December 15, 2023, in New Delhi. Our innovations, including Rabeloc IV, Sepsivac, Polycap, Resorine, Cadiflu, MycidacC, and ThRabis, reflect our dedication to addressing critical public health issues.
This recognition reaffirms our focus on innovation and our mission to contribute to a healthier, more resilient society.
